Physician profile
Muhammad U Butt
NPI 1619203403
$6,895.42
in general payments reported to CMS, 2019-2025
30 companies · $164 in 2025
The $164 reported for 2025 was less than what a typical Surgical Oncology provider received nationally (typical 2025 total: $288).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,975 · 2020: $53.89 · 2021: $1,463 · 2022: $672 · 2023: $167 · 2024: $401 · 2025: $164.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $732.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $731.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,108.85 | 2019-2022 | |
| Medical Device Business Services, INC. | $1,263.63 | 2019-2021 | |
| Davol INC. | $266.94 | 2021-2025 | Phasix Mesh, Arista Ah Flexitip |
| Abbott Laboratories | $205.25 | 2022-2023 | Ensite |
| Medtronic, INC. | $127.51 | 2021-2024 | Progrip, Emprint |
| Tela Bio, INC. | $125.91 | 2023-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Ethicon US, LLC | $81.73 | 2024 | Vistaseal, Echelon; Endopath |
| Tactile Systems Technology INC | $68.55 | 2022 | |
| Integra Lifesciences Corporation | $65.64 | 2021-2024 | Integra, Surgimend, Omnigraft |
| Becton, Dickinson and Company | $56.26 | 2022-2025 | Acumen Iq |
| Nestle Healthcare Nutrition INC. | $45.60 | 2021 | |
| C. R. Bard, INC. & Subsidiaries | $42.19 | 2025 | Phasix Mesh |
| W. L. Gore & Associates, INC. | $41.36 | 2021 | |
| Kls-Martin L.P. | $40.65 | 2020 | |
| Polynovo North America LLC | $39.48 | 2024-2025 | Novosorb Btm |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $35.22 | 2024 | |
| Baxter Healthcare | $29.65 | 2024 | Tisseel |
| Bioventus LLC | $26.16 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $24.65 | 2021 | |
| Access Pro Medical, LLC | $24.18 | 2022 | |
| Biom'Up France Sas | $24.10 | 2021 | |
| Acera Surgical, INC. | $22.21 | 2024 | Restrata Wound Matrix |
| Smith+Nephew, INC. | $20.90 | 2022 | |
| Allergan, INC. | $19.70 | 2019 | |
| Leica Microsystems INC. | $19.44 | 2022 | |
| Cardinal Health 414 LLC | $17.80 | 2021 | |
| Kerecis Limited | $15.01 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Solventum Corporation | $14.86 | 2024 | V.A.C. Veraflo Cleanse Choice, Prevena |
| Acell, INC. | $13.24 | 2020 | |
| Sirtex Medical INC | $8.75 | 2024 | Sir-Spheres Microspheres |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Muhammad Butt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.